Our previous work in transgenic Tau P301S (called PS19) mice highlighted the link between sleep disruption and AD, as these mice exhibited progressive sleep loss and hyperarousal, tau pathology, neuroinflammation, and cognitive decline with age [2]. Here, MAPT is linked to Alzheimer disease.